Introduction
A vasa previa describes an aberrant chorionic vessel directly connected to the umbilical cord circulation but running between the amniotic and the chorionic layers of the placental free membranes below the fetal presenting part. 1 Vasa previa are classically separated into 2 different categories: type I describes vessels that connect a velamentous cord to the main placental mass and type II describes vessels running between !1 accessory lobes of the placenta. 1 The classic presentation of undiagnosed vasa previa in labor is the presence of painless vaginal bleeding. This occurs mainly when the cervix is effaced and dilated and the membranes rupture spontaneously or are ruptured artificially. It can lead to rapid fetal exsanguination and death [1] [2] [3] [4] [5] and the perinatal mortality of undiagnosed vasa previa has been reported to be as high as 60%. 6 The incidence of vasa previa has been reported to range between in 1 in 1200 to 1 in 5000 pregnancies. [1] [2] [3] [4] [5] A recent systematic review of 10 cohort studies found that the incidence of vasa previa is 0.6 per 1000 pregnancies. 7 Approximately 90% of women presenting with a vasa previa also have a velamentous cord insertion (VCI) and 3-4% of women presenting with a VCI have a vasa previa. 8 Unlike the single umbilical artery cord routinely recorded by midwives at birth, these cord anomalies are only recorded when associated with perinatal complications and the placental is examined by a pathologist.
The pathophysiology of vasa previa and VCI is uncertain but it has been linked to an abnormal development of the definitive placenta. Both cord anomalies are more common in bilobate placenta, succenturiate or accessory placenta, and lowlying placenta. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] VCI and vasa previa type I are also more common in twin pregnancies and monochorionicity doubles the risk for VCI compared to dichorinicity. 11, 12 Maternal smoking has been recently reported as a risk factor for VCI and thus potentially of vasa previa. 13 Assisted reproduction technology (ART) and in vitro fertilization (IVF) in particular is associated with a higher incidence of abnormally shaped placenta, placenta previa, and cord insertion outside the placental chorionic plate. 7, 14 It has been hypothesized that these placental and cord anomalies could be due to the inadequate orientation of the IVF blastocyst at the time of implantation or to a higher incidence of vanishing twins in IVF than in spontaneous twins. 10, [14] [15] [16] [17] [18] The incidence of vasa previa has been reported to be as high as 1 in 300 pregnancies conceived after ART. 7, 14 These data suggest that the incidence of vasa previa in both singleton and multiple pregnancy gestations is likely to increase in the next decade with the increase use of ART worldwide.
Recent national guidelines, expert reviews, and a decision analysis study on the management of vasa previa recommended delivery of all women presenting with vasa previa between 34-36 weeks of gestation but none provide a specific algorithm for twins. [3] [4] [5] [6] 8, 19 Twin pregnancies are associated with specific obstetric complications and in particular with a higher incidence of premature delivery. 20 Like singletons, twins presenting with vasa previa have very poor outcomes when antenatal diagnosis is not made before the onset of labor. 21 Previous studies and reviews have not identified twin pregnancies diagnosed with vasa previa during pregnancy as requiring a different management strategy.
We present a case series and a systematic review of the literature of twin pregnancies diagnosed prenatally with vasa previa. Our aim is to evaluate the role of ultrasound imaging in optimizing the management of individual cases of twins diagnosed antenatally with vasa previa and in supporting the development of the corresponding clinical guidelines.
Materials and Methods
We have reviewed our databases for clinical cases and the international literature for published cases of twin pregnancies diagnosed prenatally with vasa previa.
Case series
The location of the placental insertion of the umbilical cord is included in our routine midtrimester transabdominal fetal detailed anatomy ultrasound protocol in targeted cases, ie, in cases of low-lying placenta, bilobate placenta, succenturiate lobed placenta, multiple pregnancies, and IVF conceptions. When a VCI is identified on transabdominal ultrasound, a transvaginal scan (TVS) is performed to exclude a vasa previa. Our units have collaborated on the use of cervical length (CL) in the management of twin pregnancies 22, 23 and are using similar protocols based on national and international guidelines for the prenatal diagnosis of vasa previa. Asymptomatic women presenting with vasa previa are followed up every 2 weeks, from 26-28 weeks until delivery, for fetal growth and well-being and with TVS for CL and vasa previa position. The timing of delivery is scheduled according to changes in CL and/or clinical symptoms (mainly uterine contractions and/ or vaginal bleeding), following a course of corticosteroids. When the CL remains stable with normal fetal development and there are no clinical symptoms delivery is planned at around 36 weeks.
Systematic review information sources and search strategy The search protocol was designed a priori and registered on PROSPERO (no. 42016050164). We performed an electronic search of the literature in PubMed and MEDLINE and selected relevant studies published from the first prenatal ultrasound description of vasa previa by Gianopoulos et al 24 in 1987 through October 20, 2016. The search was achieved using medical subject heading terms, key words, and their combination including "vasa previa," "velamentous insertion of the cord," "velamentous vessel," "membranous umbilical vessels," "twin pregnancy," "multiple pregnancy," "placenta previa," "in vitro fertilization pregnancy," "succenturiate lobe," "lowlying placenta," and "bilobate placenta" as related to "sonography," "ultrasound diagnosis," "prenatal diagnosis," and "color Doppler."
We included all cohort studies and case reports that described the prenatal diagnosis of vasa previa in women presenting with a twin pregnancy (Figure 1 ).
Systematic review eligibility criteria
The primary eligibility criteria were articles that correlated prenatal ultrasound imaging of vasa previa and pregnancy outcome. The eligibility criteria was the use of CL in the management of twin pregnancies diagnosed antenatally with vasa previa. Two authors (E.J. and R.M.) independently assessed inclusion criteria, data extraction, and analysis.
Systematic review study selection
The initial database search provided 44 reports and cross-referencing provided an additional 2 reports, making a total of 43 records after removal of 3 duplicates ( Figure 1 ). Of the 43 records screened, 13 did not include data on prenatal ultrasound imaging of vasa previa and were therefore excluded. After the second selection, letters with no description of the case, commentaries, and reviews were excluded. A further 6 reports where antenatal ultrasound was performed but cases of vasa previa were only diagnosed at delivery were further excluded leaving 13 reports for the final analysis.
Statistical analysis
Numerical data from the case series and systematic review were analyzed using the StatGraphic data analysis and statistical software package (Manugistics, Rockville, MD).
Results

Case series
The search of our databases identified 7 sets of twins diagnosed prenatally with ajog.org Systematic Reviews vasa previa, followed up using our standard protocol and confirmed at birth by detailed pathologic examination. Table 1 presents the clinical data and outcome of these cases. There were 6 cases of dichorionic-diamniotic (DCDA) twins and 1 case of monochorionic-diamniotic (MCDA) twins (case 7). Five DCDA cases were conceived following IVF. The mean (SD) gestational at time of diagnosis was 26þ5 (3þ1) weeks. In 5 cases, a VCI was detected on transabdominal ultrasound at the midtrimester examination or during a fetal growth scan follow-up. In the other 2 cases, the diagnosis of vasa previa was made at the time of the first CL measurement. In 5 cases, the CL remained >25 mm and the patients were treated conservatively without hospitalization. In 1 case, the CL was found to be 10 mm at 32þ6 weeks (case 5) and an emergency cesarean delivery was performed the next day because of vaginal bleeding. One case was complicated by placenta previa accreta (case 6) for which an emergency cesarean delivery was performed at 30þ3 weeks because of major vaginal bleeding. In the case of MCDA twins (case 7), the cord of the presenting twin (fetus 1) was inserted halfway between the lower placental edge and the cervix. On TVS, there was a large vasa previa above the internal os with nonpulsatile flow on Doppler imaging (Figure 2 ). This venous vasa previa could be traced back to the area of the VCI with color mapping. No vasa previa arteries were found. The CL was stable on followup scans and there was no ultrasound evidence of twin-to-twin transfusion syndrome (TTTS) but a 20% discrepancy in estimated fetal weight was noted from 32þ4 weeks and an elective cesarean delivery was performed at 35þ1 weeks. The mean (SD) gestational at the time of delivery was 34.2 (2.1) weeks.
Systematic review report characteristics
We found data on 56 cases of vasa previa diagnosed prenatally in twin pregnancies, confirmed at birth and included in 3 case report series, [25] [26] [27] 9 retrospective cohort studies, 6 ,17,28-34 and 1 retrospective casecontrol study 35 ( Table 2 ). The incidence of twin pregnancies diagnosed with vasa previa on ultrasound during pregnancy for which ultrasound data and postnatal confirmation were available in the cohort and case-control studies was 11.0% (48 cases of twins for 438 pregnancies diagnosed with vasa previa).
Systematic review synthesis of results
Of the 34 cases for which data on chorionicity were available, there were 19 DCDA and 15 MCDA twin pregnancies. In 1 case report, the diagnosis of vasa previa was made at the time of laser photocoagulation of communicating anastomoses in a MCDA twin pregnancy complicated by TTTS. 27 The authors of 2 case reports 26, 27 and of 4 cohorts [31] [32] [33] [34] described the use of CL measurements in their management of twin pregnancies presenting with vasa previa on prenatal ultrasound. Only 2 authors of cohort studies included perinatal data on individual twin pregnancies that were diagnosed by ultrasound antenatally. 29, 31 Detailed measurements of CL were only provided in 2 cases in a cohort series 31 and in 1 case report. 27 Table 3 displays the baseline perinatal characteristics of 12 cases of vasa previa diagnosed antenatally and verified by clinical documentation at birth and/or a pathology report. In 7 cases, there was information on additional ultrasound findings including a low-lying placenta and VCI in 3 cases 25, 26 and VCI alone in 2 cases.
17,28
The mean (SD) gestational at the time of diagnosis was 23þ6 (7þ1) weeks. Information on the mode of delivery was available in 8 cases including 5 elective and 3 emergency cesarean deliveries, 2 for premature rupture of the Systematic Reviews ajog.org membranes 27,28 and 1 for preeclampsia. 17 The mean (SD) gestational age at time of delivery was 32þ6 (3þ5) weeks. The neonatal outcome of the corresponding 24 fetuses including 2 stillbirths and 2 neonatal deaths.
29,31
Comment Principal findings of the study Our review indicates a total incidence of 11.0% of twin pregnancies in cohort studies on the prenatal diagnosis of vasa previa. Our case series and systematic review confirm that like for singletons, the outcome for twin fetuses and neonates is excellent when the vasa previa is diagnosed antenatally. Determination of chorionicity and serial measurements of CL can provide individualized management pathways for twin pregnancies with vasa previa and in particular in the timing of delivery or the need for emergent cesarean delivery before a planned delivery around 36 weeks.
Comparison with existing literature A 97% survival rate has been reported in cases of vasa previa diagnosis prenatally compared to only 44% when the diagnosis was made during delivery. 6 A recent systematic review of ultrasound in the diagnosis of vasa previa including 2 prospective and 6 retrospective cohort studies of which 6 had a poor methodology found prenatal detection rates ranging between 53% (10/19) and 100% for a total of 442,633 women, including 138 cases of vasa previa. 36 Four of the 8 studies used TVS for primary assessment, while the remaining 4 studies used transabdominal ultrasound and only used TVS when a vasa previa was suspected on the transabdominal scan. The gestational age at the time of diagnosis was reported in 5 studies and ranged from 18þ0 to 26þ6 weeks. The data of twin pregnancies were not analyzed separately by the authors. The accuracy of ultrasound at 9-13 weeks' gestation in screening for vasa previa was evaluated prospectively in case-control study. 37 However, the definitive placenta is only fully formed by 10-11 weeks of gestation 1 making it difficult in many cases to predict the final position of the umbilical cord and to identify placental morphologic anomalies, in particular in twins. The performance of ultrasound in screening for and diagnosing vasa previa is considered more efficient at around mid-gestation [3] [4] [5] 36 and the mean gestational age at diagnosis in twins, in our series and in the literature, was 26þ5 and 23þ6 weeks, respectively.
Cases of vasa previa in both singletons and twins described in the literature present pulsatile flow velocity waveforms indicative of an arterial previa vessel. [3] [4] [5] 6, 31 One of our case (case 7) presented with venous vasa previa and the arteries were not visible on TVS color mapping (Figure 2, B) . We found no similar case described in the international literature. A venous vasa previa could be easily mistaken for "free loop" of cord 3 and thus in particular in this case it may be useful to trace the route of the vessel to the VIC and to demonstrate that it does not "move" with changing maternal position and/or between ultrasound examinations.
Several studies have suggested that the majority of cases of vasa previa can be suspected prenatally by routinely evaluating the placental cord insertion in pregnancies with low-lying placenta and the placental morphology. 4, [6] [7] [8] 29, 38 The incidence of succenturiate lobes and other morphological placental anomalies is higher in twin pregnancies. 1, 11, 39, 40 A VCI of one of the umbilical cords is 8 times more common in twins than in singletons. 39 The odd ratio for vasa previa in pregnancies presenting with a bilobate placenta or with succenturiate lobe has been evaluated to be 22.11 in twin pregnancies. 39 Five of the 7 cases of our series ( Table 1 ) and 5 of the 8 cases described in details in the literature (Table 3) presented with a VCI. One cases in our series and 3 in the literature also presented a low-lying placenta or placenta previa. Thus, the placental cord insertion should be documented at the second trimester scan in all twin pregnancies. The largest study to date on the perinatal outcome of vasa previa is based on a retrospective multicentric cohort of 155 women with vasa previa diagnosed at the midtrimester scan and it included 50 (32.3%) cases associated with a bilobate or succenturiate lobed placentas and 95 (61%) with low-lying placenta. 6 Only 7 cases (4.5%) were twin pregnancies and the authors provided no data on chorionicity and individual outcome. Overall only half of the cohort studies included in the present review provide detailed data on chorionicity (Table 2) . Similarly, to singleton pregnancies, a ruptured vasa previa in the presenting twin of a dichorionic pair will lead to acute hemorrhage in the corresponding twin. By contrast, in monochorionic twins, the acute hemorrhage in the presenting twin may also lead to acute blood shift and rapid exsanguination in the cotwin due to the presence of intertwin placental vascular anastomoses. van Steenis et al 41 reported recently a case of double fatal outcome in monochorionic twins and reviewed similar cases published in the international literature since the first case reports in 1939. Including their case, there were 3 other recent cases reported in the last 5 years in the international literature but surprisingly none were diagnosed prenatally [42] [43] [44] and were, therefore, not included in the present review.
Clinical implications
The ultimate management goal of confirmed vasa previa prenatally is to deliver before labor and in particular before the rupture of membranes while minimizing the impact of iatrogenic prematurity. There is no consensus about the time of delivery in cases of Jauniaux. Management of vasa previa in twins. Am J Obstet Gynecol 2017.
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confirmed vasa previa and the currently low prevalence of prenatal diagnosis of this condition precludes any prospective trials to evaluate the ideal timing. Data from a decision analysis study comparing 11 strategies for delivery timing in a patient with vasa previa found that delivery between 34-36 weeks balances the risk of premature rupture of the membranes and subsequent fetal hemorrhage and death vs the risks of prematurity. 19 This study did not differentiate between singleton and twin pregnancies.
A cost-utility analysis based on a decision-analytic model comparing relevant strategies and life-long outcomes for mother and infant has shown that screening all twin pregnancies for vasa previa with transvaginal ultrasound is cost-effective and has an incremental cost-effectiveness ratio of $5488 per quality-adjusted life-years gained. 45 46, 47 With the increased use of single embryo transfer procedures, the incidence of multiple-birth deliveries has decreased during that period from 50-39%, however as vasa previa is more common in all pregnancies resulting from ART, targeted screening for vasa previa should be offered in that population at the midtrimester ultrasound examination. A recent systematic review and meta-analysis of the association between placental implantation abnormalities including placenta previa, placenta accreta, vasa previa, and VIC preterm delivery in singleton gestations found a perinatal death rate risk ratio of 4.52 (95% confidence interval, 2.77e7.39) for vasa previa. 2 The associated complications of prematurity are, in many cases, the result of iatrogenic preterm birth in an effort to prevent stillbirth. Antenatal hospitalization to allow for closer surveillance for signs of labor in a unit with appropriate neonatal facilities has also been proposed for all pregnancies presenting with vasa previa from 30-32 weeks of gestation [3] [4] [5] 31 but the evidence is weak and based on low-quality evidence. 4 No specific data are available for twins pregnancies diagnosed with vasa previa.
Twin pregnancies are at higher risks of preterm delivery and a recent retrospective cohort study of 441 women with twin pregnancies found that integration of serial measurements of CL using a stepwise algorithm in asymptomatic women with twin gestations can improve the detection of women at risk of preterm birth. 48 Women with vasa previa in a monochorionic twin pregnancy also require regular follow-up to assess the risks of TTTS and thus determining twin chorionicity is pivotal in the management of these high-risk pregnancies. We use CL >25 mm as a threshold for conservative management in asymptomatic women with twins. To minimize the impact of prematurity, twins diagnosed with vasa previa with uncomplicated antenatal course and stable CL could be scheduled for cesarean delivery at 36 weeks. However, the data on CL from our series (Table 1) and from the literature (Table 3) suggest that a CL !30 mm could be a better limit to allow for conservative management in women with twins and vasa previa. 
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These data need to be prospectively evaluated by a multicentric study.
Strengths and weaknesses
This study provides data supporting the need to screen for vasa previa in twin pregnancies, in particular those resulting from IVF. A recent systematic review and meta-analysis found no clear evidence of benefit from planned cesarean delivery for term twin pregnancies with leading cephalic presentation 49 and thus for women opting for a vaginal birth it is essential to exclude a vasa previa antenatally. Our data also support the determination of chorionicity and use of transvaginal sonographic assessment of CL to evaluate the individual risk of premature delivery in twins presenting with vasa previa. Overall our study is the first to highlight the need to incorporate these parameters in local protocols and national guidelines in the perinatal management of twins. The weakness of the study is its retrospective nature and the lack of specific details on twins in most cohort series. In twins diagnosed with vasa previa antenatally in the literature, information on chorionicity was available in only 34 of 56 (60.7%) cases and CL measurements used by only 6 authors of 13 thus limiting the number of cases available for analysis.
Conclusions
There is enough evidence to warrant guidelines for targeted screening with TVS and color Doppler in twin pregnancies to rule out vasa previa, as the relative obstetric risk is significantly higher than in singletons. In twin pregnancies, the ultrasound follow-up should also be tailored according to chorionicity, changes in CL, and clinical symptoms. Outpatient management is possible if there is no evidence of cervical shortening on TVS and there are no symptoms of bleeding or preterm uterine activity. Multicentric prospective vasa previa screening studies with detailed data on twins including their chorionicity are required to develop more efficient management protocols tailored to the need of individual cases.
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